Commission's public consultation on electromagnetic effects on human health:
This article was originally published in Clinica
November 3 is the deadline by which interested parties must send their comments to the European Commission's Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR) on its preliminary opinion on the possible effects of electromagnetic fields (EMF) on human health, including those produced by medical equipment. The Commission intends to prepare a report to the Council and has asked the SCENIHR to update a previous official EU opinion in this area, as well as to monitor new information that may influence the assessment of risks to human health in this area.
You may also be interested in...
TTS Pharma CEO Mark Tucker discusses his ambition to bring a legal CBD oil to the UK market, following the recent submission of a European Union novel food application.
Italy Round-Up: Mylan And Polifarma Strike Deal, OTC Market Stable, Cholesterol-Lowering Probiotic Launch
The latest news from Italy's OTC and supplements markets, including the latest sales figures, business deals, product launches, ad regulation and local association activities.
Sandoz CEO Richard Saynor has pledged that the company will ensure stable pricing for essential coronavirus-related medicines amid concerns over how the outbreak will affect the supply chain.